Clinical Trials Browser

Castrate Resistant Prostate Cancer (CRPC) × AP 1903 reagent × Clear all

NCT00868595 2019-10-08

MTD Study of Vaccine BP-GMAX-CD1 Plus AP1903 to Treat Castrate Resistant Prostate Cancer

Phase 1 Completed

Castrate Resistant Prostate Cancer (CRPC)